Posters

Filters

Clear Filters
All Days Sun, Sep 27 Mon, Sep 28 Tue, Sep 29

Sunday, September 27

3:00 PM - 4:00 PM ET

2275 - Prognostic Value of Harvesting at Least 15 Lymph Nodes across Surgery Alone and Neoadjuvant Chemotherapy with or without Radiotherapy in Resected Pancreatic Cancer
Speaker: Yang, Ching-chieh, MD, PhD, RT - Chimei Medical Center
3:00 PM - 4:00 PM ET

2276 - Impact of Post-SABR Lymphopenia on Outcomes of SABR Combined with ICI or TKI in Extrahepatic Metastatic Hepatocellular Carcinoma
Speaker: Kim, Nalee, MD, PhD - Samsung Medical Center, seoul, Seoul
3:00 PM - 4:00 PM ET

2277 - Evaluating Stereotactic Radiosurgery as an Alternative to Whole Brain Radiotherapy for NSCLC Patients with 15 or More Brain Metastases
Speaker: Yang, Wen-Chi, MD, PhD - National Taiwan University Hospital, Taipei, 100
3:00 PM - 4:00 PM ET

2278 - A Novel Radiotherapy Immobilization Device Enabling Pre-Positioned Hippocampal Avoidance for Hippocampal Sparing During Whole-Brain Radiotherapy
Speaker: Ye, Chunhua - Fuding Hospital, Fuding
3:00 PM - 4:00 PM ET

2279 - Functional Network Characterizations of Glioma Infiltration
Speaker: Yeo, Wan-Jin, PhD - University of California, San Francisco, San Francisco, CA
3:00 PM - 4:00 PM ET

2280 - A Prospective Pathological Study to Refine Radiotherapy CTV Delineation for ESCC After Neoadjuvant Chemoimmunotherapy
Speaker: Yin, Hang - Harbin Medical University Cancer Hospital, Harbin, Heilongjia
3:00 PM - 4:00 PM ET

2281 - Early MRI Radiomics-Based Triage Model Predicts Response and Survival after Bevacizumab in Recurrent Glioblastoma
Speaker: You, Weir Chiang, MD, PhD - Taichung Veterans General Hospital, Taichung, Taichung
3:00 PM - 4:00 PM ET

2282 - Serplulimab plus Chemoradiotherapy for Unresectable Locally Advanced Esophageal Squamous Cell Carcinoma: A Single-Arm, Multicenter, Phase I/II Trial (SCR-ESCC-02)
Speaker: Yu, Wen, MD, PhD - Shanghai Chest Hospital Shanghai Jiao Tong University, Shanghai, Shanghai
3:00 PM - 4:00 PM ET

2283 - Radiosensitization and Active Antitumor Effect of Antibody-Drug Conjugates on Brain Metastases after Whole Brain Radiation
Speaker: Yu, Yao, MD - Memorial Sloan Kettering Cancer Center, New York, NY
3:00 PM - 4:00 PM ET

2284 - Association Between Frailty and Progression Free Survival in Glioblastoma
Speaker: Yukselen Guney, Yildiz, MD, PhD - Ankara Onkoloji Hospital, Ankara, Ankara
3:00 PM - 4:00 PM ET

2285 - N-Terminal Androgen Receptor Antagonists Offer Superior Tumor Suppression on Glioblastoma than C-Terminal Inhibitors
Speaker: Zhang, Chi, MD, PhD - Mayo Clinic Arizona, Phoenix, AZ
3:00 PM - 4:00 PM ET

2286 - Induction Chemotherapy Exposure as a Determinant of Local Control Independent of Radiation Modality in Pancreatic Cancer
Speaker: Zhang, Ella, BS - Yale School of Medicine, New Haven, CT